SG Americas Securities’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $166K | Sell |
19,847
-20,684
| -51% | -$217K | ﹤0.01% | 2724 |
|
|
2025
Q4 | $584K | Buy |
40,531
+13,931
| +52% | +$174K | ﹤0.01% | 2403 |
|
|
2025
Q3 | $257K | Buy |
+26,600
| New | +$235K | ﹤0.01% | 2589 |
|
|
2025
Q1 | – | Sell |
-10,375
| Closed | -$80K | – | 3707 |
|
|
2024
Q4 | $80K | Sell |
10,375
-3,570
| -26% | -$33.5K | ﹤0.01% | 2800 |
|
|
2024
Q3 | $146K | Buy |
+13,945
| New | +$170K | ﹤0.01% | 2760 |
|
|
2024
Q1 | – | Sell |
-30,813
| Closed | -$553K | – | 3362 |
|
|
2023
Q4 | $553K | Buy |
+30,813
| New | +$543K | 0.01% | 1414 |
|
|
2023
Q1 | – | Sell |
-5,035
| Closed | -$114K | – | 3503 |
|
|
2022
Q4 | $114K | Sell |
5,035
-4,957
| -50% | -$112K | ﹤0.01% | 2635 |
|
|
2022
Q3 | $264K | Sell |
9,992
-21,138
| -68% | -$627K | ﹤0.01% | 2098 |
|
|
2022
Q2 | $769K | Buy |
31,130
+10,704
| +52% | +$267K | 0.01% | 1549 |
|
|
2022
Q1 | $678K | Sell |
20,426
-12,581
| -38% | -$349K | 0.01% | 1694 |
|
|
2021
Q4 | $1.08M | Sell |
33,007
-712
| -2% | -$24.2K | 0.01% | 1595 |
|
|
2021
Q3 | $1.41M | Buy |
+33,719
| New | +$1.21M | 0.01% | 1599 |
|
|
2021
Q2 | – | Sell |
-21,033
| Closed | -$717K | – | 3176 |
|
|
2021
Q1 | $717K | Buy |
21,033
+18,133
| +625% | +$773K | ﹤0.01% | 1761 |
|
|
2020
Q4 | $132K | Sell |
2,900
-78,684
| -96% | -$2.75M | ﹤0.01% | 2897 |
|
|
2020
Q3 | $2.25M | Buy |
81,584
+71,974
| +749% | +$2.35M | 0.01% | 679 |
|
|
2020
Q2 | $354K | Buy |
9,610
+1,747
| +22% | +$65.1K | ﹤0.01% | 2394 |
|
|
2020
Q1 | $255K | Sell |
7,863
-438
| -5% | -$18.2K | ﹤0.01% | 2344 |
|
|
2019
Q4 | $340K | Sell |
8,301
-45,822
| -85% | -$1.81M | ﹤0.01% | 2095 |
|
|
2019
Q3 | $1.93M | Buy |
54,123
+42,982
| +386% | +$1.74M | 0.02% | 986 |
|
|
2019
Q2 | $572K | Sell |
11,141
-168,138
| -94% | -$8.39M | ﹤0.01% | 1802 |
|
|
2019
Q1 | $10.3M | Buy |
179,279
+169,571
| +1,747% | +$8.4M | 0.09% | 215 |
|
|
2018
Q4 | $407K | Buy |
9,708
+6,286
| +184% | +$369K | ﹤0.01% | 1999 |
|
|
2018
Q3 | $258K | Buy |
3,422
+931
| +37% | +$67.1K | ﹤0.01% | 2444 |
|
|
2018
Q2 | $179K | Buy |
+2,491
| New | +$119K | ﹤0.01% | 2674 |
|
|
2018
Q1 | – | Sell |
-24,116
| Closed | -$802K | – | 3495 |
|
|
2017
Q4 | $802K | Buy |
24,116
+5,339
| +28% | +$161K | 0.01% | 1532 |
|
|
2017
Q3 | $619K | Buy |
+18,777
| New | +$423K | 0.01% | 1654 |
|
|
2017
Q2 | – | Sell |
-31,686
| Closed | -$612K | – | 3447 |
|
|
2017
Q1 | $612K | Buy |
+31,686
| New | +$611K | 0.01% | 1708 |
|
Other funds holding RGNX
RG
VCM
IHAM
SG Americas Securities's RGNX Position: Q1 2026 in Review
SG Americas Securities reduced its Regenxbio (RGNX) stake by 51% in Q1 2026, selling an estimated $217K and leaving 19,847 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.
SG Americas Securities first reported a position in RGNX in Q1 2017 and has held it in 27 quarters since. The position peaked at $10.3M in Q1 2019. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- SG Americas Securities held 19,847 shares of Regenxbio worth $166K as of Q1 2026.
- SG Americas Securities sold 20,684 Regenxbio shares in Q1 2026, an estimated $217K.
- Regenxbio made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2724 holding.
- SG Americas Securities first reported a position in Regenxbio in Q1 2017 and has held it in 27 quarters since.
- SG Americas Securities's Regenxbio position peaked at $10.3M in Q1 2019.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.